High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Link
http://link.springer.com/article/10.1007/s11060-018-2928-z/fulltext.html
Reference17 articles.
1. Miletic H, Niclou SP, Johansson M, Bjerkvig R (2009) Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opin Ther Targets 13:455–468. https://doi.org/10.1517/14728220902806444
2. Lu KV, Bergers G (2013) Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma. CNS Oncol 2:49–65. https://doi.org/10.2217/cns.12.36
3. Shen CC, Cheng WY, Chiao MT, Liang YJ, Mao TF, Liu BS (2016) Two novel heparin-binding vascular endothelial growth factor splices, L-VEGF144 and L-VEGF138, are expressed in human glioblastoma cells. Curr Neurovasc Res 13:207–218
4. Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R (2000) The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83:63–68. https://doi.org/10.1054/bjoc.2000.1279
5. Huez I, Bornes S, Bresson D, Creancier L, Prats H (2001) New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 15:2197–2210. https://doi.org/10.1210/mend.15.12.0738
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain;Cancers;2022-08-11
2. Radiosurgery for Glioblastoma;Neurosurgery Clinics of North America;2021-01
3. Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors;Cells;2019-12-18
4. Identification of the shortest splice variant of Dp71, together with five known variants, in glioblastoma cells;Biochemical and Biophysical Research Communications;2019-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3